Ultragenyx Pharmaceutical (RARE) Financials: Revenue & Earnings
RARE$17.17+0.42 +2.49%
$1.69B
Market Cap
—
P/E
—
Forward P/E
—
Score
Ultragenyx Pharmaceutical (RARE) Financials: Revenue & Earnings
RARE price $17.17 +0.42 +2.49%
- Ticker
- RARE
- Price
- $17.17
- Change
- +0.42 +2.49%
- Market cap ?
- $1.69B
- Beta ?
- 0.32
- Sector
- Healthcare
- Industry
- Biotechnology
Fair value
RARE fair value $40.29. Price $17.17. Price is 57% below fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 111.98M. Growth 11.79%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 98.59M. Net debt 842.00M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-03 | — | -1.10 | — | 182.49M |
| 2026-08-04 | -0.90 | -1.22 | 214.00M | 183.08M |
| 2026-05-05 | -1.84 | -1.49 | 136.00M | 158.19M |
| 2026-02-12 | -1.29 | -1.20 | 207.00M | 198.60M |
| 2025-11-04 | -1.81 | -1.23 | 159.93M | 199.77M |
| 2025-08-05 | -1.17 | -1.27 | 166.50M | 165.95M |
| 2025-05-06 | -1.57 | -1.54 | 139.29M | 162.40M |
| 2025-02-13 | -1.39 | -1.32 | 164.88M | 158.71M |
| 2024-11-05 | -1.40 | -1.45 | 139.49M | 146.54M |
| 2024-08-01 | -1.52 | -1.64 | 147.03M | 123.18M |
| 2024-05-02 | -2.03 | -1.72 | 108.83M | 116.01M |
| 2024-02-15 | -1.52 | -1.65 | 127.39M | 119.38M |
| 2023-11-02 | -2.23 | -2.08 | 98.05M | 110.02M |
| 2023-08-03 | -2.25 | -2.11 | 108.31M | 104.80M |
| 2023-05-04 | -2.33 | -1.97 | 100.50M | 104.69M |
| 2023-02-16 | -2.16 | -2.03 | 103.35M | 105.11M |
| 2022-11-02 | -3.50 | -1.81 | 90.70M | 96.46M |
| 2022-07-28 | -2.26 | -1.72 | 89.34M | 87.78M |
| 2022-05-05 | -2.19 | -1.76 | 79.94M | 83.65M |
| 2022-02-10 | -1.79 | -1.32 | 83.39M | 83.80M |
| 2021-11-02 | -1.08 | -1.43 | 81.65M | 82.38M |
| 2021-08-02 | -1.45 | -1.28 | 86.97M | 86.97M |
| 2021-05-04 | -2.03 | -1.25 | 99.39M | 89.28M |
| 2021-02-11 | -1.34 | -1.06 | 91.54M | 225.67M |
| 2020-10-27 | -1.13 | -1.24 | 81.47M | 90.84M |
| 2020-07-30 | -0.82 | -1.56 | 61.71M | 231.79M |
| 2020-05-06 | -2.04 | -1.60 | 36.31M | 29.76M |
| 2020-02-13 | -1.64 | -1.61 | 35.59M | 36.25M |
| 2019-11-05 | -1.96 | -1.71 | 25.80M | 22.11M |
| 2019-08-01 | -1.72 | -1.73 | 24.15M | 23.87M |
| 2019-05-06 | -1.82 | -1.73 | 18.17M | 17.37M |
| 2019-02-19 | -1.73 | -1.74 | 16.26M | 16.82M |
| 2018-11-05 | -1.74 | -1.94 | 11.76M | 13.25M |
| 2018-08-02 | -1.87 | -2.10 | 12.79M | 25.11M |
| 2018-05-07 | 0.62 | -0.60 | 10.68M | 3.27M |
| 2018-02-20 | -2.27 | -2.00 | 2.41M | 2.54M |
| 2017-11-02 | -1.87 | -1.87 | 198.00K | 97.48K |
| 2017-07-27 | -1.72 | -1.73 | — | — |
| 2017-05-04 | -1.63 | -1.70 | — | 104.91K |
| 2017-02-16 | -1.75 | -1.74 | 5.00K | 4.91K |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-15 | Horn Howard | Sell | 7.07K | $15.27 | 107.90K |
| 2026-09-15 | Huizenga Theodore Alan | Sell | 1.28K | $13.57 | 17.41K |
| 2026-09-03 | Huizenga Theodore Alan | Sell | 161 | $13.99 | 2.25K |
| 2026-08-03 | Parschauer Karah Herdman | Sell | 1.90K | $24.92 | 47.35K |
| 2026-08-03 | Horn Howard | Sell | 4.70K | $24.92 | 117.02K |
| 2026-07-01 | Horn Howard | Sell | 4.70K | $33.13 | 155.64K |
| 2026-06-15 | Sanders Corazon (Corsee) D. | Sell | 2.00K | $25.05 | 50.10K |
| 2026-06-15 | Parschauer Karah Herdman | Sell | 1.90K | $24.62 | 46.75K |
| 2026-06-01 | Horn Howard | Sell | 4.65K | $23.77 | 110.60K |
| 2026-05-18 | SULIMAN SHEHNAAZ | Sell | 5.74K | $25.12 | 144.19K |
| 2026-05-14 | Fust Matthew K | Buy | 7.75K | — | — |
| 2026-05-14 | Fust Matthew K | Buy | 14.06K | $25.80 | 362.70K |
| 2026-05-14 | SULIMAN SHEHNAAZ | Buy | 7.75K | — | — |
| 2026-05-14 | SULIMAN SHEHNAAZ | Buy | 14.06K | $25.80 | 362.70K |
| 2026-05-14 | Ray Amrit | Buy | 7.75K | — | — |
| 2026-05-14 | Ray Amrit | Buy | 14.06K | $25.80 | 362.70K |
| 2026-05-14 | Sanders Corazon (Corsee) D. | Buy | 7.75K | — | — |
| 2026-05-14 | Sanders Corazon (Corsee) D. | Buy | 14.06K | $25.80 | 362.70K |
| 2026-05-14 | NARACHI MICHAEL | Buy | 7.75K | — | — |
| 2026-05-14 | NARACHI MICHAEL | Buy | 14.06K | $25.80 | 362.70K |
| 2026-05-14 | WELCH DANIEL G | Buy | 7.75K | — | — |
| 2026-05-14 | WELCH DANIEL G | Buy | 14.06K | $25.80 | 362.70K |
| 2026-05-14 | Dunsire Deborah | Buy | 7.75K | — | — |
| 2026-05-14 | Dunsire Deborah | Buy | 14.06K | $25.80 | 362.70K |
| 2026-05-05 | Crombez Eric | Sell | 344 | $24.96 | 8.59K |
| 2026-05-01 | Horn Howard | Sell | 4.68K | $24.90 | 116.61K |
| 2026-04-22 | Huizenga Theodore Alan | Buy | 20.24K | — | — |
| 2026-04-22 | Huizenga Theodore Alan | Buy | 7.35K | $24.61 | 180.83K |
| 2026-04-16 | KAKKIS EMIL D | Buy | 76.75K | — | — |
| 2026-04-16 | KAKKIS EMIL D | Buy | 132.69K | $24.52 | 3.25M |
| 2026-04-16 | Huang Dennis Karl | Buy | 23.12K | — | — |
| 2026-04-16 | Huang Dennis Karl | Buy | 79.94K | $24.52 | 1.96M |
| 2026-04-16 | Pinion John Richard | Buy | 23.12K | — | — |
| 2026-04-16 | Pinion John Richard | Buy | 79.94K | $24.52 | 1.96M |
| 2026-04-16 | Parschauer Karah Herdman | Buy | 28.89K | — | — |
| 2026-04-16 | Parschauer Karah Herdman | Buy | 49.96K | $24.52 | 1.23M |
| 2026-04-16 | Harris Erik | Buy | 28.89K | — | — |
| 2026-04-16 | Harris Erik | Buy | 49.96K | $24.52 | 1.23M |
| 2026-04-16 | Crombez Eric | Buy | 34.67K | — | — |
| 2026-04-16 | Crombez Eric | Buy | 59.95K | $24.52 | 1.47M |
| 2026-04-16 | Horn Howard | Buy | 34.67K | — | — |
| 2026-04-16 | Horn Howard | Buy | 59.95K | $24.52 | 1.47M |
| 2026-04-01 | Horn Howard | Sell | 4.68K | $20.97 | 98.20K |
| 2026-03-10 | Parschauer Karah Herdman | Sell | 3.51K | $22.67 | 79.53K |
| 2026-03-06 | Parschauer Karah Herdman | Sell | 6.02K | $21.40 | 128.79K |
| 2026-03-03 | Horn Howard | Sell | 1.64K | $22.40 | 36.62K |
| 2026-03-02 | Pinion John Richard | Sell | 10.03K | $22.80 | 228.66K |
| 2026-03-02 | Harris Erik | Sell | 10.54K | $22.80 | 240.29K |
| 2026-03-02 | KAKKIS EMIL D | Sell | 54.40K | $22.80 | 1.24M |
| 2026-03-02 | Parschauer Karah Herdman | Sell | 8.13K | $22.80 | 185.48K |
| 2026-03-02 | Huizenga Theodore Alan | Sell | 148 | $23.39 | 3.46K |
| 2026-03-02 | Huizenga Theodore Alan | Sell | 1.63K | $22.80 | 37.21K |
| 2026-03-02 | Horn Howard | Sell | 5.29K | $22.80 | 120.61K |
| 2026-03-02 | Horn Howard | Sell | 3.12K | $22.54 | 70.30K |
| 2026-03-02 | Crombez Eric | Sell | 7.03K | $22.80 | 160.26K |
| 2026-03-02 | Huang Dennis Karl | Sell | 999 | $23.39 | 23.37K |
| 2026-03-01 | Pinion John Richard | Buy | 11.14K | — | — |
| 2026-03-01 | Harris Erik | Buy | 11.64K | — | — |
| 2026-03-01 | KAKKIS EMIL D | Buy | 71.18K | — | — |
| 2026-03-01 | Parschauer Karah Herdman | Buy | 11.14K | — | — |
| 2026-03-01 | Horn Howard | Buy | 6.14K | — | — |
| 2026-03-01 | Crombez Eric | Buy | 11.64K | — | — |
| 2026-03-01 | Huang Dennis Karl | Buy | 11.14K | — | — |
| 2026-02-02 | Horn Howard | Sell | 3.06K | $23.56 | 72.12K |
| 2026-01-02 | Horn Howard | Sell | 3.15K | $22.84 | 71.95K |
| 2025-12-29 | Huizenga Theodore Alan | Sell | 85 | $34.38 | 2.92K |
| 2025-12-10 | Horn Howard | Sell | 3.08K | $36.38 | 112.09K |
| 2025-10-13 | Horn Howard | Sell | 7.94K | $31.51 | 250.25K |
| 2025-09-18 | Huizenga Theodore Alan | Sell | 64 | $29.17 | 1.87K |
| 2025-09-12 | Parschauer Karah Herdman | Sell | 2.45K | $31.17 | 76.37K |
| 2025-09-05 | Huizenga Theodore Alan | Sell | 84 | $31.39 | 2.64K |
| 2025-06-20 | Sanders Corazon (Corsee) D. | Sell | 2.40K | $37.39 | 89.92K |
| 2025-05-15 | SULIMAN SHEHNAAZ | Buy | 5.74K | — | — |
| 2025-05-15 | SULIMAN SHEHNAAZ | Buy | 10.79K | $34.84 | 375.82K |
| 2025-05-15 | WELCH DANIEL G | Buy | 5.74K | — | — |
| 2025-05-15 | WELCH DANIEL G | Buy | 10.79K | $34.84 | 375.82K |
| 2025-05-15 | Sanders Corazon (Corsee) D. | Buy | 5.74K | — | — |
| 2025-05-15 | Sanders Corazon (Corsee) D. | Buy | 10.79K | $34.84 | 375.82K |
| 2025-05-15 | NARACHI MICHAEL | Buy | 5.74K | — | — |
| 2025-05-15 | NARACHI MICHAEL | Buy | 10.79K | $34.84 | 375.82K |
| 2025-05-15 | Fust Matthew K | Buy | 5.74K | — | — |
| 2025-05-15 | Fust Matthew K | Buy | 10.79K | $34.84 | 375.82K |
| 2025-05-15 | Dunsire Deborah | Buy | 5.74K | — | — |
| 2025-05-15 | Dunsire Deborah | Buy | 10.79K | $34.84 | 375.82K |
| 2025-05-15 | Ray Amrit | Buy | 5.74K | — | — |
| 2025-05-15 | Ray Amrit | Buy | 10.79K | $34.84 | 375.82K |
| 2025-05-05 | Crombez Eric | Sell | 520 | $39.24 | 20.40K |
| 2025-04-21 | Crombez Eric | Sell | 242 | $35.11 | 8.50K |
| 2025-03-06 | Horn Howard | Sell | 1.78K | $40.40 | 72.11K |
| 2025-03-03 | Kassberg Thomas Richard | Sell | 6.03K | $42.10 | 253.78K |
| 2025-03-03 | Kassberg Thomas Richard | Sell | 508 | $42.92 | 21.80K |
| 2025-03-03 | Parschauer Karah Herdman | Sell | 12.85K | $42.10 | 540.82K |
| 2025-03-03 | Crombez Eric | Sell | 8.95K | $42.10 | 376.58K |
| 2025-03-03 | Pinion John Richard | Sell | 31 | $42.92 | 1.33K |
| 2025-03-03 | Pinion John Richard | Sell | 14.44K | $42.10 | 607.88K |
| 2025-03-03 | KAKKIS EMIL D | Sell | 73.43K | $42.10 | 3.09M |
| 2025-03-03 | Harris Erik | Sell | 15.10K | $42.10 | 635.84K |
| 2025-03-03 | Huang Dennis Karl | Sell | 1.35K | $42.92 | 57.86K |
| 2025-03-03 | Huizenga Theodore Alan | Sell | 967 | $42.10 | 40.71K |
| 2025-03-03 | Huizenga Theodore Alan | Sell | 141 | $42.92 | 6.05K |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 329, holders +15 vs prior quarter. Ownership 105.45%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| BLACKROCK, INC. | 10.65M | 3.35M | +45.96% | 355.75M |
| RTW INVESTMENTS, LP | 7.80M | 4.15M | +113.68% | 260.34M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6.79M | 1.40M | +26.07% | 226.72M |
| AQR CAPITAL MANAGEMENT LLC | 6.56M | 1.98M | +43.31% | 214.14M |
| STATE STREET CORP | 6.16M | 1.14M | +22.65% | 205.64M |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.30M | 106.66K | +2.55% | 143.46M |
| TWO SIGMA INVESTMENTS, LP | 3.62M | 1.42M | +64.17% | 120.91M |
| SANDS CAPITAL MANAGEMENT, LLC | 3.16M | -56.16K | -1.75% | 105.46M |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2.94M | 1.51M | +105.42% | 98.16M |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 2.85M | 656.75K | +29.97% | 95.09M |
| GEODE CAPITAL MANAGEMENT, LLC | 2.58M | 729.44K | +39.44% | 86.12M |
| BELLEVUE GROUP AG | 1.98M | -397.23K | -16.69% | 66.20M |
| D. E. SHAW & CO., INC. | 1.73M | 469.18K | +37.21% | 57.77M |
| SOFINNOVA INVESTMENTS, INC. | 1.72M | 1.37M | +390.72% | 57.35M |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.58M | 1.10M | +229.17% | 52.76M |
| GW&K INVESTMENT MANAGEMENT, LLC | 1.48M | -134.25K | -8.31% | 49.46M |
| MPM BIOIMPACT LLC | 1.42M | 1.42M | New | 47.35M |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.36M | 552.39K | +68.70% | 45.30M |
| MORGAN STANLEY | 1.32M | -175.72K | -11.71% | 44.24M |
| WELLINGTON MANAGEMENT GROUP LLP | 1.25M | -1.39M | -52.65% | 41.75M |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1.24M | -185.28K | -12.99% | 41.46M |
| BANK OF AMERICA CORP /DE/ | 1.15M | 101.91K | +9.74% | 38.35M |
| CANDRIAM S.C.A. | 1.00M | -94.34K | -8.61% | 33.42M |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 967.86K | -250.92K | -20.59% | 32.32M |
| JEFFERIES FINANCIAL GROUP INC. | 929.63K | 929.63K | New | 31.04M |
Earnings and financials
Ultragenyx Pharmaceutical Inc. (RARE) trades at $17.17, with a market cap of $1.69B and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn